Results
Sai Parenterals Reports 134% Revenue Growth to ₹3.81B in FY26
Sai Parenterals achieved consolidated revenue of ₹3,809.98 million in FY26, representing 134% growth driven by the Noumed Pharmaceuticals acquisition.
The company completed its IPO raising ₹285 crore
